AquaBounty Surges After FDA Lifts Ban on ‘Frankenfish’ Salmon

AquaBounty Technologies Inc. soared after the U.S. Food and Drug Administration ended a three-year ban on genetically engineered salmon, a food that critics call “Frankenfish.”

The FDA’s move removed a prohibition on importing the fish, permitting AquaBounty to accept genetically engineered salmon eggs at its Indiana facility to be raised as food, according to a March 8 statement from the agency.

AquaBounty shares surged as much as 75 percent to $3.91 in New York, the biggest intraday gain since January 2018.

The FDA determined in 2015 that the company’s genetically engineered AquaAdvantage salmon is safe to eat. It’s engineered to ...